Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Novartis AG

NVSEF•PNK
Healthcare
Drug Manufacturers - General
$170.20
$8.49(5.25%)
U.S. Market opens in 8h 20m

Novartis AG (NVSEF) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap324.8B
P/E Ratio23.16
EPS (TTM)$7.16
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$167.31
3 Months$152.22
1 Year Target$145.40

NVSEF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVSEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.16, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $145.40.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.16 and a market capitalization of 324.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.25%
5-Day Change
5.39%
1-Month Change
12.08%
3-Month Change
33.90%
6-Month Change
34.24%
Year-to-Date (YTD) Change
23.33%
1-Year Change
60.57%
3-Year Change
104.52%
5-Year Change
100.26%
All-Time (Max) Change
322.86%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

758,830 Employees
IPO DateApr 26, 2010
CountryCH
Actively Trading

Frequently Asked Questions